NEWS ROOMOUR COMMITMENT(760) 477-8900
    OTC BB: XNNH

SuperVision

a class by itself

Unlike most post Desert Storm Gen I, Gen II or Gen III image intensified night vision devices, SuperVision has been built from the ground up, especially designed for military, law enforcement and security professionals and their special requirements in an increasing dangerous global environment. While there are plenty of night vision and thermal imaging products on the market, only SuperVision is so unique that it's in a class by itself.

NightHunter

Recognized as "best of breed" by the US Army and Marine Corps, our NightHunter ultra-high intensity, multi-purpose illumination systems have distinguished themselves in the global war on terrorism. NightHunters provide unique capabilities that enable users to see first and act first, with the versatility to quickly adapt to and dominate changing conditions at night. Our NightHunter 3 represents the state-of-the-art in ultra-high intensity illumination and is feature packed for performance and versatility, tested and qualified by the US Army for crew served weapons, handheld or from vehicles.

November, 10 2014
Xenonics Announces $300,000 Purchase Order

CARLSBAD, CALIFORNIA -- November 10, 2014 -- XENONICS HOLDINGS, INC. (OTCQB:XNNH) announced today that it has been awarded a purchase order valued in excess of $300,000 for its NightHunter high-intensity illumination devices.  This order was received from Aardvark Tactical, Inc. (ATI), Azusa, California on behalf of the U.S. Marine Corps.

October, 27 2014
Xenonics Announces New Purchase Orders

CARLSBAD, CALIFORNIA October 27, 2014 -- XENONICS HOLDINGS, INC. (OTCQB:XNNH) announced today that it has been awarded purchase orders valued at approximately $200,000 for its NightHunter high-intensity illumination devices.  These orders were received primarily from Aardvark Tactical, Inc. (ATI), Azusa, California on behalf of the U.S. Air Force.

VIEW ALL UPDATES
 
Supervision Nighthunter Testimonials Investors
GSA dod emall
E-mail Newsletter
Copyright © 2008 Xenonics Holdings, Inc.